Kura Oncology, Inc. (KURA)
9.68
+0.74
(+8.28%)
USD |
NASDAQ |
Apr 17, 16:00
9.59
-0.09
(-0.93%)
Pre-Market: 08:30
Kura Oncology SG&A Expense (Quarterly) : 39.14M for Dec. 31, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Abbott Laboratories | 3.74B |
| Lexicon Pharmaceuticals, Inc. | 8.757M |
| Viemed Healthcare, Inc. | 34.52M |
| Liquidia Corp. | 48.24M |
| Agenus, Inc. | 12.30M |